Matinas biopharma holdings, inc. (MTNB)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
ASSETS:
Current assets:
Cash and cash equivalents

10,077

22,170

32,664

36,830

39,412

12,446

6,632

8,903

4,263

7,306

9,000

11,266

15,834

4,105

6,219

578

1,673

3,226

4,362

6,605

4,616

2,590

5,006

6,647

8,558

10,840

Marketable securities

61,089

5,604

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash - security deposit

-

-

-

-

-

-

-

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

89

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposit

-

-

-

-

-

-

-

-

155

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

150

250

200

100

100

100

200

-

-

155

155

-

-

155

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

1,386

494

391

-

692

249

475

502

1,017

-

-

304

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

155

155

-

55

55

100

100

100

100

100

100

-

-

-

0

Grant receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

79

-

-

-

-

-

-

-

Contract Research Receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

59

30

-

-

-

-

-

Prepaid expenses and other current assets

2,671

1,897

-

-

-

538

-

-

-

-

-

317

803

-

254

139

138

231

342

114

93

114

108

38

87

84

Total current assets

73,988

29,922

34,250

37,425

39,903

13,085

7,524

9,342

4,893

7,963

10,173

11,739

16,793

4,565

6,529

773

1,911

3,559

4,884

6,880

4,840

2,805

5,114

6,685

8,645

10,924

Non-current assets:
Leasehold improvements and equipment - net

1,697

1,749

1,806

1,791

1,522

2,042

2,097

1,811

1,705

1,569

1,460

1,170

344

356

368

382

364

377

365

363

339

339

357

361

364

93

Operating lease right-of-use assets - net

3,643

3,761

3,877

3,990

4,102

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease right-of-use assets - net

94

116

141

166

203

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

In-process research and development

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

3,017

0

-

-

-

-

Goodwill

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,336

1,384

1,384

1,384

0

-

-

-

-

Restricted cash - security deposits

336

336

386

486

486

461

436

-

-

535

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total non-current assets

10,124

10,317

10,565

10,789

10,668

6,857

-

-

-

6,459

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash - security deposit

-

-

-

-

-

-

-

535

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash - security deposit

-

-

-

-

-

-

-

-

535

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets including long term security deposit

-

-

-

-

-

-

-

-

-

-

535

536

540

540

54

54

115

115

216

216

216

216

316

316

315

315

Total assets

84,113

40,240

44,816

48,214

50,572

19,943

14,411

16,043

11,489

14,423

16,523

17,799

22,031

9,816

11,306

5,564

6,745

8,406

9,868

11,862

9,797

3,361

5,788

7,363

9,326

11,333

LIABILITIES AND STOCKHOLDERS' EQUITY:
Current liabilities:
Accounts payable

953

679

685

548

394

295

303

497

473

582

341

453

1,247

475

209

475

620

497

282

745

466

271

211

281

242

396

Note payable

-

-

-

-

79

199

319

0

42

170

297

0

47

118

188

-

-

0

10

10

10

-

-

-

-

-

Accrued expenses

1,106

1,939

1,462

1,274

1,010

1,086

758

939

462

959

753

731

471

829

941

845

689

610

549

339

780

802

764

547

386

462

Stock dividends payable

-

-

-

1,174

1,174

1,174

1,174

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities - current

440

423

407

390

374

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease liabilities - current

42

54

66

75

81

83

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

0

0

0

29

74

119

164

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent liability

-

-

-

-

-

-

-

-

-

-

395

11

11

11

11

10

10

9

8

7

5

0

-

-

-

-

Lease liability

-

-

-

-

-

-

83

52

51

26

19

18

10

9

9

9

0

11

22

33

44

44

44

43

44

0

Total current liabilities

2,542

3,097

2,622

3,463

3,115

2,839

2,639

1,489

1,030

1,769

1,882

1,335

1,952

1,444

1,360

1,341

1,320

1,128

872

1,136

1,307

1,118

1,020

872

673

858

Non-current liabilities:
Deferred tax liability

341

341

-

-

-

341

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

341

341

341

-

848

848

848

848

1,205

1,205

1,205

1,205

1,205

1,205

1,205

1,205

1,253

-

-

0

-

-

-

-

Operating lease liabilities - net of current portion

3,579

3,695

3,809

3,918

4,020

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease liabilities - net of current portion

46

54

62

72

89

107

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent liability

-

-

-

-

-

512

501

489

472

455

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

781

-

-

-

-

-

-

-

Deferred Tax Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,253

1,253

-

-

-

-

-

Contingent Consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

843

843

-

-

-

-

-

Lease liability - net of current portion

-

-

-

-

-

-

122

103

116

67

47

51

13

16

19

20

-

0

0

0

0

15

22

33

43

0

Stock dividends payable - long term

-

-

-

-

-

-

0

587

589

601

603

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total non-current liabilities

3,967

4,091

4,213

4,332

4,450

961

-

-

-

1,972

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

6,509

7,188

6,835

7,796

7,566

3,801

4,111

3,517

3,055

3,741

3,738

2,591

3,171

2,666

2,584

2,567

2,525

2,333

2,907

3,233

3,404

1,133

1,043

905

716

858

Commitments

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

0

-

-

-

0

-

-

-

0

Stockholders' equity:
Series B Convertible preferred stock, stated value $1,000 per share, 8,000 shares authorized as of March 31, 2020 and December 31, 2019; 4,552 and 4,577 shares issued and outstanding as of March 31, 2020 and December 31, 2019; (liquidation preference - $4,552,000 at March 31, 2020)

3,964

3,985

-

-

-

-

-

-

-

-

-

-

6,048

-

6,086

-

-

0

-

-

-

-

-

0

0

-

Common stock par value $0.0001 per share, 500,000,000 shares authorized at March 31, 2020 and December 31, 2019; 197,202,938 and 163,156,984 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

19

16

16

14

14

11

9

9

9

9

9

9

9

5

5

5

5

5

5

5

4

3

3

3

3

3

Additional paid-in capital

162,520

113,427

112,745

104,601

103,284

72,294

60,926

58,784

58,206

56,230

54,686

53,045

52,478

36,237

35,917

30,047

29,646

29,253

28,136

27,649

23,010

16,276

15,749

14,849

14,576

14,302

Accumulated deficit

-89,423

-84,377

-78,804

-73,813

-69,995

-65,944

-62,318

-58,795

-55,384

-51,274

-47,646

43,643

-39,675

-35,179

-33,287

-27,055

-25,431

-23,187

-21,181

-19,026

-16,621

-14,051

-11,007

-8,395

-5,969

-3,830

Accumulated other comprehensive income/(loss)

522

-0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

77,603

33,051

37,980

40,418

43,005

16,141

10,300

12,526

8,433

10,681

12,784

15,208

18,859

7,149

8,721

2,997

4,220

6,072

6,961

8,628

6,392

2,227

4,745

6,457

8,609

10,474

Total liabilities and stockholders' equity

84,113

40,240

44,816

48,214

50,572

19,943

14,411

16,043

11,489

14,423

16,523

17,799

22,031

9,816

11,306

5,564

6,745

8,406

9,868

11,862

9,797

3,361

5,788

7,363

9,326

11,333

Series A Convertible Preferred Stock [Member]
Preferred stock, value

-

-

-

5,583

5,583

5,583

-

-

-

5,716

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B Convertible Preferred Stock [Member]
Preferred stock, value

-

-

4,023

4,031

4,119

4,196

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-